Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity

Metabolism. 2020 Jul:108:154224. doi: 10.1016/j.metabol.2020.154224. Epub 2020 Apr 7.

Authors

David C Klonoff¹, Guillermo E Umpierrez²

Affiliations

¹ Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, United States of America. Electronic address: dklonoff@diabetestechnology.org.
² Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States of America.

No abstract available

Keywords: COVID-19; Corticosteroid; Diabetes; Risk; Telemedicine.

Publication types

Letter
Comment

MeSH terms

Betacoronavirus*
COVID-19
Coronavirus Infections*
Diabetes Mellitus*
Humans
Pandemics*
Pneumonia, Viral*
Risk Factors
SARS-CoV-2